Drug-biomolecule interactions: fluorescence studies on interaction of aminonaphthalenesulfonic acid derivatives with serum albumins.
The binding of the three aminonaphthalenesulfonic acid derivatives to human and bovine serum albumins was studied by measuring the fluorescence enhancement of the compounds. The number of binding sites of human and bovine serum albumins for these compounds appears to be one and two, respectively, under the experimental conditions. As the molar ratio of the fluorescent compounds to bovine serum albumin increased, the binding sites appeared to increase for the compounds. The quenching of the native fluorescence of albumin was examined by the successive addition of methanolic solutions of these compounds. 1-Anilinonaphthalene-8-sulfonate quenched the protein fluorescence to a greater extent than the other compounds studied, indicating that 1-anilinonaphthalene-8-sulfonate molecules are bound more closely to the tryptophan residues of albumin. The finding that the three compounds did not quench the fluorescence of tryptophan dissolved in water indicates no direct molecular interaction between tryptophan and the three fluorescent probes. The driving force for binding may be due to the structural characteristics of the amino acid sequence surrounding the tryptophan residues.
D000817:Anilino Naphthalenesulfonates / Q000032:analysis; D000818:Animals; D001665:Binding Sites; D002417:Cattle; D006801:Humans; D009282:Naphthalenesulfonates / Q000032:analysis*; D011485:Protein Binding; D012709:Serum Albumin / Q000032:analysis*; D012710:Serum Albumin, Bovine / Q000032:analysis*; D013050:Spectrometry, Fluorescence
D000817:Anilino Naphthalenesulfonates; D009282:Naphthalenesulfonates; D012709:Serum Albumin; D012710:Serum Albumin, Bovine